nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—Irinotecan—lung cancer	0.275	0.418	CbGbCtD
Ciclesonide—CYP2D6—Gefitinib—lung cancer	0.0479	0.0726	CbGbCtD
Ciclesonide—CYP2D6—Vinorelbine—lung cancer	0.0369	0.0559	CbGbCtD
Ciclesonide—CYP3A4—Topotecan—lung cancer	0.0333	0.0505	CbGbCtD
Ciclesonide—CYP3A4—Gefitinib—lung cancer	0.0304	0.0461	CbGbCtD
Ciclesonide—CYP3A4—Teniposide—lung cancer	0.0295	0.0447	CbGbCtD
Ciclesonide—CYP2D6—Erlotinib—lung cancer	0.0283	0.0429	CbGbCtD
Ciclesonide—CYP3A4—Vinorelbine—lung cancer	0.0234	0.0355	CbGbCtD
Ciclesonide—CYP2D6—Vinblastine—lung cancer	0.0227	0.0345	CbGbCtD
Ciclesonide—CYP3A4—Crizotinib—lung cancer	0.0187	0.0283	CbGbCtD
Ciclesonide—CYP3A4—Erlotinib—lung cancer	0.018	0.0273	CbGbCtD
Ciclesonide—CYP3A4—Paclitaxel—lung cancer	0.0165	0.025	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—lung cancer	0.0162	0.0246	CbGbCtD
Ciclesonide—CYP3A4—Vinblastine—lung cancer	0.0144	0.0219	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—lung cancer	0.014	0.0212	CbGbCtD
Ciclesonide—CYP3A4—Etoposide—lung cancer	0.013	0.0197	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—lung cancer	0.0119	0.0181	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—lung cancer	0.00888	0.0135	CbGbCtD
Ciclesonide—Amcinonide—ANXA1—lung cancer	0.00255	0.449	CrCbGaD
Ciclesonide—Hydrocortisone—ANXA1—lung cancer	0.00108	0.189	CrCbGaD
Ciclesonide—Clobetasol propionate—CYP1A1—lung cancer	0.000461	0.081	CrCbGaD
Ciclesonide—Prednisolone—CYP2A6—lung cancer	0.000432	0.076	CrCbGaD
Ciclesonide—Hypertension—Vinorelbine—lung cancer	0.000396	0.00179	CcSEcCtD
Ciclesonide—Infestation NOS—Paclitaxel—lung cancer	0.000394	0.00179	CcSEcCtD
Ciclesonide—Infestation—Paclitaxel—lung cancer	0.000394	0.00179	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—lung cancer	0.000394	0.00179	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000394	0.00179	CcSEcCtD
Ciclesonide—Immune system disorder—Irinotecan—lung cancer	0.000392	0.00178	CcSEcCtD
Ciclesonide—Mediastinal disorder—Irinotecan—lung cancer	0.000391	0.00177	CcSEcCtD
Ciclesonide—Chest pain—Vinorelbine—lung cancer	0.00039	0.00177	CcSEcCtD
Ciclesonide—Arthralgia—Vinorelbine—lung cancer	0.00039	0.00177	CcSEcCtD
Ciclesonide—Dyspnoea—Topotecan—lung cancer	0.00039	0.00177	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—lung cancer	0.000388	0.00176	CcSEcCtD
Ciclesonide—Dyspnoea—Erlotinib—lung cancer	0.000386	0.00175	CcSEcCtD
Ciclesonide—Dyspepsia—Topotecan—lung cancer	0.000385	0.00174	CcSEcCtD
Ciclesonide—Urinary tract infection—Paclitaxel—lung cancer	0.000383	0.00174	CcSEcCtD
Ciclesonide—Conjunctivitis—Paclitaxel—lung cancer	0.000383	0.00174	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000383	0.00173	CcSEcCtD
Ciclesonide—Immune system disorder—Gemcitabine—lung cancer	0.000382	0.00173	CcSEcCtD
Ciclesonide—Mediastinal disorder—Gemcitabine—lung cancer	0.000381	0.00173	CcSEcCtD
Ciclesonide—Dyspepsia—Erlotinib—lung cancer	0.000381	0.00172	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Topotecan—lung cancer	0.000377	0.00171	CcSEcCtD
Ciclesonide—Fatigue—Topotecan—lung cancer	0.000377	0.00171	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Erlotinib—lung cancer	0.000373	0.00169	CcSEcCtD
Ciclesonide—Fatigue—Erlotinib—lung cancer	0.000373	0.00169	CcSEcCtD
Ciclesonide—Epistaxis—Paclitaxel—lung cancer	0.000372	0.00169	CcSEcCtD
Ciclesonide—Rash—Teniposide—lung cancer	0.000372	0.00168	CcSEcCtD
Ciclesonide—Dermatitis—Teniposide—lung cancer	0.000372	0.00168	CcSEcCtD
Ciclesonide—Infection—Vinorelbine—lung cancer	0.000372	0.00168	CcSEcCtD
Ciclesonide—Sinusitis—Paclitaxel—lung cancer	0.00037	0.00168	CcSEcCtD
Ciclesonide—Headache—Teniposide—lung cancer	0.00037	0.00167	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—lung cancer	0.000369	0.00167	CcSEcCtD
Ciclesonide—Back pain—Irinotecan—lung cancer	0.000366	0.00166	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methotrexate—lung cancer	0.00036	0.00163	CcSEcCtD
Ciclesonide—Back pain—Gemcitabine—lung cancer	0.000356	0.00161	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—lung cancer	0.000356	0.00161	CcSEcCtD
Ciclesonide—Immune system disorder—Cisplatin—lung cancer	0.000356	0.00161	CcSEcCtD
Ciclesonide—Haemoglobin—Paclitaxel—lung cancer	0.000356	0.00161	CcSEcCtD
Ciclesonide—Mediastinal disorder—Cisplatin—lung cancer	0.000355	0.00161	CcSEcCtD
Ciclesonide—Rhinitis—Paclitaxel—lung cancer	0.000355	0.00161	CcSEcCtD
Ciclesonide—Haemorrhage—Paclitaxel—lung cancer	0.000354	0.0016	CcSEcCtD
Ciclesonide—Pharyngitis—Paclitaxel—lung cancer	0.000351	0.00159	CcSEcCtD
Ciclesonide—Nausea—Teniposide—lung cancer	0.00035	0.00159	CcSEcCtD
Ciclesonide—Urticaria—Topotecan—lung cancer	0.000347	0.00157	CcSEcCtD
Ciclesonide—Weight increased—Docetaxel—lung cancer	0.000341	0.00155	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000341	0.00154	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—lung cancer	0.000336	0.00152	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—lung cancer	0.000334	0.00151	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—lung cancer	0.000334	0.00151	CcSEcCtD
Ciclesonide—Dyspnoea—Vinorelbine—lung cancer	0.000333	0.00151	CcSEcCtD
Ciclesonide—Cough—Irinotecan—lung cancer	0.00033	0.00149	CcSEcCtD
Ciclesonide—Hypertension—Irinotecan—lung cancer	0.000326	0.00148	CcSEcCtD
Ciclesonide—Immune system disorder—Etoposide—lung cancer	0.000326	0.00148	CcSEcCtD
Ciclesonide—Mediastinal disorder—Etoposide—lung cancer	0.000326	0.00147	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—lung cancer	0.000325	0.00147	CcSEcCtD
Ciclesonide—Asthenia—Vinblastine—lung cancer	0.000323	0.00146	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000323	0.00146	CcSEcCtD
Ciclesonide—Fatigue—Vinorelbine—lung cancer	0.000322	0.00146	CcSEcCtD
Ciclesonide—Cough—Gemcitabine—lung cancer	0.000321	0.00146	CcSEcCtD
Ciclesonide—Immune system disorder—Paclitaxel—lung cancer	0.00032	0.00145	CcSEcCtD
Ciclesonide—Mediastinal disorder—Paclitaxel—lung cancer	0.000319	0.00145	CcSEcCtD
Ciclesonide—Hypertension—Gemcitabine—lung cancer	0.000318	0.00144	CcSEcCtD
Ciclesonide—Epistaxis—Docetaxel—lung cancer	0.000315	0.00143	CcSEcCtD
Ciclesonide—Asthenia—Topotecan—lung cancer	0.000314	0.00142	CcSEcCtD
Ciclesonide—Chest pain—Gemcitabine—lung cancer	0.000313	0.00142	CcSEcCtD
Ciclesonide—Arthralgia—Gemcitabine—lung cancer	0.000313	0.00142	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—lung cancer	0.000311	0.00141	CcSEcCtD
Ciclesonide—Asthenia—Erlotinib—lung cancer	0.00031	0.00141	CcSEcCtD
Ciclesonide—Dysgeusia—Etoposide—lung cancer	0.000308	0.00139	CcSEcCtD
Ciclesonide—Infection—Irinotecan—lung cancer	0.000306	0.00139	CcSEcCtD
Ciclesonide—Back pain—Etoposide—lung cancer	0.000304	0.00138	CcSEcCtD
Ciclesonide—Dysgeusia—Paclitaxel—lung cancer	0.000302	0.00137	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—lung cancer	0.000302	0.00137	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—lung cancer	0.000301	0.00136	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—lung cancer	0.0003	0.00136	CcSEcCtD
Ciclesonide—Infection—Gemcitabine—lung cancer	0.000299	0.00135	CcSEcCtD
Ciclesonide—Back pain—Paclitaxel—lung cancer	0.000298	0.00135	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—lung cancer	0.000298	0.00135	CcSEcCtD
Ciclesonide—Dizziness—Vinblastine—lung cancer	0.000298	0.00135	CcSEcCtD
Ciclesonide—Urticaria—Vinorelbine—lung cancer	0.000297	0.00135	CcSEcCtD
Ciclesonide—Hydrocortisone—ABCG2—lung cancer	0.000296	0.052	CrCbGaD
Ciclesonide—Dizziness—Topotecan—lung cancer	0.000289	0.00131	CcSEcCtD
Ciclesonide—Dizziness—Erlotinib—lung cancer	0.000286	0.0013	CcSEcCtD
Ciclesonide—Headache—Vinblastine—lung cancer	0.000282	0.00128	CcSEcCtD
Ciclesonide—Angioedema—Paclitaxel—lung cancer	0.000282	0.00128	CcSEcCtD
Ciclesonide—Infection—Cisplatin—lung cancer	0.000278	0.00126	CcSEcCtD
Ciclesonide—Rash—Topotecan—lung cancer	0.000276	0.00125	CcSEcCtD
Ciclesonide—Dermatitis—Topotecan—lung cancer	0.000275	0.00125	CcSEcCtD
Ciclesonide—Dyspnoea—Irinotecan—lung cancer	0.000275	0.00125	CcSEcCtD
Ciclesonide—Cough—Etoposide—lung cancer	0.000274	0.00124	CcSEcCtD
Ciclesonide—Headache—Topotecan—lung cancer	0.000274	0.00124	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000274	0.00124	CcSEcCtD
Ciclesonide—Rash—Erlotinib—lung cancer	0.000273	0.00124	CcSEcCtD
Ciclesonide—Dermatitis—Erlotinib—lung cancer	0.000273	0.00123	CcSEcCtD
Ciclesonide—Palpitations—Paclitaxel—lung cancer	0.000272	0.00123	CcSEcCtD
Ciclesonide—Dyspepsia—Irinotecan—lung cancer	0.000272	0.00123	CcSEcCtD
Ciclesonide—Hypertension—Etoposide—lung cancer	0.000271	0.00123	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—lung cancer	0.000271	0.00123	CcSEcCtD
Ciclesonide—Headache—Erlotinib—lung cancer	0.000271	0.00123	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—lung cancer	0.000271	0.00123	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—lung cancer	0.000271	0.00123	CcSEcCtD
Ciclesonide—Cough—Paclitaxel—lung cancer	0.000269	0.00122	CcSEcCtD
Ciclesonide—Asthenia—Vinorelbine—lung cancer	0.000268	0.00122	CcSEcCtD
Ciclesonide—Dyspnoea—Gemcitabine—lung cancer	0.000268	0.00121	CcSEcCtD
Ciclesonide—Chest pain—Etoposide—lung cancer	0.000268	0.00121	CcSEcCtD
Ciclesonide—Nausea—Vinblastine—lung cancer	0.000267	0.00121	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000266	0.00121	CcSEcCtD
Ciclesonide—Hypertension—Paclitaxel—lung cancer	0.000266	0.00121	CcSEcCtD
Ciclesonide—Fatigue—Irinotecan—lung cancer	0.000266	0.0012	CcSEcCtD
Ciclesonide—Arthralgia—Paclitaxel—lung cancer	0.000262	0.00119	CcSEcCtD
Ciclesonide—Chest pain—Paclitaxel—lung cancer	0.000262	0.00119	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—lung cancer	0.000261	0.00118	CcSEcCtD
Ciclesonide—Nausea—Topotecan—lung cancer	0.00026	0.00118	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000259	0.00118	CcSEcCtD
Ciclesonide—Fatigue—Gemcitabine—lung cancer	0.000259	0.00117	CcSEcCtD
Ciclesonide—Nausea—Erlotinib—lung cancer	0.000257	0.00116	CcSEcCtD
Ciclesonide—Dry mouth—Paclitaxel—lung cancer	0.000257	0.00116	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—lung cancer	0.000256	0.00116	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000255	0.00116	CcSEcCtD
Ciclesonide—Infection—Etoposide—lung cancer	0.000255	0.00115	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—lung cancer	0.000253	0.00114	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—lung cancer	0.000251	0.00114	CcSEcCtD
Ciclesonide—Infection—Paclitaxel—lung cancer	0.00025	0.00113	CcSEcCtD
Ciclesonide—Dyspnoea—Cisplatin—lung cancer	0.00025	0.00113	CcSEcCtD
Ciclesonide—Dizziness—Vinorelbine—lung cancer	0.000247	0.00112	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—lung cancer	0.000242	0.0011	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—lung cancer	0.000242	0.0011	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000242	0.0011	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—lung cancer	0.000241	0.00109	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—lung cancer	0.000241	0.00109	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000239	0.00108	CcSEcCtD
Ciclesonide—Rash—Vinorelbine—lung cancer	0.000236	0.00107	CcSEcCtD
Ciclesonide—Dermatitis—Vinorelbine—lung cancer	0.000236	0.00107	CcSEcCtD
Ciclesonide—Headache—Vinorelbine—lung cancer	0.000234	0.00106	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—lung cancer	0.000234	0.00106	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—lung cancer	0.000234	0.00106	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—lung cancer	0.000231	0.00105	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000229	0.00104	CcSEcCtD
Ciclesonide—Dyspnoea—Etoposide—lung cancer	0.000229	0.00104	CcSEcCtD
Ciclesonide—Methylprednisolone—ABCB1—lung cancer	0.000228	0.0401	CrCbGaD
Ciclesonide—Cough—Docetaxel—lung cancer	0.000228	0.00103	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—lung cancer	0.000227	0.00103	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—lung cancer	0.000226	0.00102	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—lung cancer	0.000225	0.00102	CcSEcCtD
Ciclesonide—Dyspnoea—Paclitaxel—lung cancer	0.000224	0.00102	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—lung cancer	0.000222	0.00101	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—lung cancer	0.000222	0.00101	CcSEcCtD
Ciclesonide—Nausea—Vinorelbine—lung cancer	0.000222	0.00101	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Etoposide—lung cancer	0.000222	0.001	CcSEcCtD
Ciclesonide—Dyspepsia—Paclitaxel—lung cancer	0.000221	0.001	CcSEcCtD
Ciclesonide—Asthenia—Irinotecan—lung cancer	0.000221	0.001	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—lung cancer	0.000221	0.001	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—lung cancer	0.000218	0.000985	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000218	0.000985	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—lung cancer	0.000217	0.000985	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000217	0.000984	CcSEcCtD
Ciclesonide—Fatigue—Paclitaxel—lung cancer	0.000217	0.000983	CcSEcCtD
Ciclesonide—Haemorrhage—Methotrexate—lung cancer	0.000216	0.00098	CcSEcCtD
Ciclesonide—Asthenia—Gemcitabine—lung cancer	0.000216	0.000977	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—lung cancer	0.000215	0.000973	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—lung cancer	0.000213	0.000965	CcSEcCtD
Ciclesonide—Infection—Docetaxel—lung cancer	0.000212	0.00096	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—lung cancer	0.00021	0.000951	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—lung cancer	0.000209	0.000945	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—lung cancer	0.000209	0.000945	CcSEcCtD
Ciclesonide—Dizziness—Irinotecan—lung cancer	0.000204	0.000924	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—lung cancer	0.000204	0.000923	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—lung cancer	0.000203	0.000919	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—lung cancer	0.000203	0.000919	CcSEcCtD
Ciclesonide—Asthenia—Cisplatin—lung cancer	0.000201	0.00091	CcSEcCtD
Ciclesonide—Urticaria—Paclitaxel—lung cancer	0.0002	0.000905	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—lung cancer	0.000197	0.000892	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—lung cancer	0.000196	0.000887	CcSEcCtD
Ciclesonide—Immune system disorder—Methotrexate—lung cancer	0.000195	0.000885	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—lung cancer	0.000195	0.000883	CcSEcCtD
Ciclesonide—Rash—Irinotecan—lung cancer	0.000195	0.000881	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—lung cancer	0.000194	0.00088	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000194	0.00088	CcSEcCtD
Ciclesonide—Headache—Irinotecan—lung cancer	0.000193	0.000875	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—lung cancer	0.00019	0.000861	CcSEcCtD
Ciclesonide—Rash—Gemcitabine—lung cancer	0.000189	0.000858	CcSEcCtD
Ciclesonide—Dermatitis—Gemcitabine—lung cancer	0.000189	0.000857	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—lung cancer	0.000188	0.000853	CcSEcCtD
Ciclesonide—Headache—Gemcitabine—lung cancer	0.000188	0.000853	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—lung cancer	0.000188	0.000851	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—lung cancer	0.000188	0.00085	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—lung cancer	0.000187	0.000849	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—lung cancer	0.000186	0.000842	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—lung cancer	0.000184	0.000835	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000184	0.000834	CcSEcCtD
Ciclesonide—Asthenia—Etoposide—lung cancer	0.000184	0.000834	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—lung cancer	0.000184	0.000833	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—lung cancer	0.000183	0.00083	CcSEcCtD
Ciclesonide—Prednisone—ALB—lung cancer	0.000183	0.0321	CrCbGaD
Ciclesonide—Back pain—Methotrexate—lung cancer	0.000182	0.000825	CcSEcCtD
Ciclesonide—Asthenia—Paclitaxel—lung cancer	0.000181	0.000818	CcSEcCtD
Ciclesonide—Nausea—Gemcitabine—lung cancer	0.000178	0.000809	CcSEcCtD
Ciclesonide—Rash—Cisplatin—lung cancer	0.000177	0.0008	CcSEcCtD
Ciclesonide—Dermatitis—Cisplatin—lung cancer	0.000176	0.000799	CcSEcCtD
Ciclesonide—Prednisone—ABCB1—lung cancer	0.000174	0.0307	CrCbGaD
Ciclesonide—Dizziness—Etoposide—lung cancer	0.00017	0.000769	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—lung cancer	0.000169	0.000766	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—lung cancer	0.000169	0.000765	CcSEcCtD
Ciclesonide—Dizziness—Paclitaxel—lung cancer	0.000166	0.000754	CcSEcCtD
Ciclesonide—Nausea—Cisplatin—lung cancer	0.000166	0.000754	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000166	0.00145	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000165	0.00145	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000164	0.00144	CbGpPWpGaD
Ciclesonide—Cough—Methotrexate—lung cancer	0.000164	0.000744	CcSEcCtD
Ciclesonide—Rash—Etoposide—lung cancer	0.000162	0.000733	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—lung cancer	0.000162	0.000732	CcSEcCtD
Ciclesonide—Prednisolone—ABCB1—lung cancer	0.000161	0.0283	CrCbGaD
Ciclesonide—Headache—Etoposide—lung cancer	0.000161	0.000728	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—lung cancer	0.00016	0.000726	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—lung cancer	0.00016	0.000726	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—GSTA3—lung cancer	0.00016	0.0014	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.00016	0.0014	CbGpPWpGaD
Ciclesonide—Dysgeusia—Doxorubicin—lung cancer	0.00016	0.000723	CcSEcCtD
Ciclesonide—Rash—Paclitaxel—lung cancer	0.000159	0.000719	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000158	0.00139	CbGpPWpGaD
Ciclesonide—Dermatitis—Paclitaxel—lung cancer	0.000158	0.000718	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTA3—lung cancer	0.000158	0.00139	CbGpPWpGaD
Ciclesonide—Back pain—Doxorubicin—lung cancer	0.000158	0.000715	CcSEcCtD
Ciclesonide—Headache—Paclitaxel—lung cancer	0.000158	0.000714	CcSEcCtD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000156	0.00137	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000155	0.00136	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—EP300—lung cancer	0.000155	0.00136	CbGpPWpGaD
Ciclesonide—Asthenia—Docetaxel—lung cancer	0.000153	0.000693	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000153	0.00134	CbGpPWpGaD
Ciclesonide—Infection—Methotrexate—lung cancer	0.000153	0.000692	CcSEcCtD
Ciclesonide—Nausea—Etoposide—lung cancer	0.000152	0.00069	CcSEcCtD
Ciclesonide—Nausea—Paclitaxel—lung cancer	0.000149	0.000677	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000149	0.00131	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000148	0.0013	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTA4—lung cancer	0.000147	0.00128	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000146	0.00128	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000145	0.00127	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTA4—lung cancer	0.000144	0.00127	CbGpPWpGaD
Ciclesonide—Palpitations—Doxorubicin—lung cancer	0.000144	0.000653	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000144	0.00126	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTA2—lung cancer	0.000143	0.00125	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000143	0.00125	CbGpPWpGaD
Ciclesonide—Cough—Doxorubicin—lung cancer	0.000142	0.000645	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—lung cancer	0.000141	0.000639	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—lung cancer	0.000141	0.000638	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000141	0.00123	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—lung cancer	0.00014	0.00123	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00014	0.000634	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.00014	0.00123	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000139	0.00122	CbGpPWpGaD
Ciclesonide—Arthralgia—Doxorubicin—lung cancer	0.000139	0.000629	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—lung cancer	0.000139	0.000629	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000139	0.00122	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTA1—lung cancer	0.000138	0.00121	CbGpPWpGaD
Ciclesonide—Dyspnoea—Methotrexate—lung cancer	0.000137	0.000621	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—lung cancer	0.000136	0.000615	CcSEcCtD
Ciclesonide—Dyspepsia—Methotrexate—lung cancer	0.000135	0.000613	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000135	0.00118	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000135	0.00118	CbGpPWpGaD
Ciclesonide—Rash—Docetaxel—lung cancer	0.000134	0.000609	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—lung cancer	0.000134	0.000608	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000134	0.00118	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000134	0.00117	CbGpPWpGaD
Ciclesonide—Headache—Docetaxel—lung cancer	0.000134	0.000605	CcSEcCtD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000133	0.00117	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000133	0.000601	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—lung cancer	0.000133	0.0006	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—lung cancer	0.000132	0.000599	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000131	0.00115	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	0.00013	0.00114	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.00013	0.00114	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.00013	0.00114	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000128	0.00113	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000128	0.00112	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—UGT1A1—lung cancer	0.000128	0.00112	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000128	0.00112	CbGpPWpGaD
Ciclesonide—Nausea—Docetaxel—lung cancer	0.000127	0.000574	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	0.000126	0.00111	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000126	0.0011	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000123	0.00108	CbGpPWpGaD
Ciclesonide—Hydrocortisone—ABCB1—lung cancer	0.000123	0.0216	CrCbGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000122	0.00107	CbGpPWpGaD
Ciclesonide—Urticaria—Methotrexate—lung cancer	0.000122	0.000553	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000121	0.000549	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000121	0.00106	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000121	0.00106	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.00012	0.00105	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.00012	0.00105	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.00012	0.00105	CbGpPWpGaD
Ciclesonide—Dyspnoea—Doxorubicin—lung cancer	0.000119	0.000537	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000118	0.00104	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000118	0.00103	CbGpPWpGaD
Ciclesonide—Dyspepsia—Doxorubicin—lung cancer	0.000117	0.000531	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000116	0.00102	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000115	0.00052	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—lung cancer	0.000115	0.00052	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—RB1—lung cancer	0.000114	0.001	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000114	0.000998	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000113	0.000988	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000112	0.000986	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000112	0.000983	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000111	0.000977	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.00011	0.000968	CbGpPWpGaD
Ciclesonide—Asthenia—Methotrexate—lung cancer	0.00011	0.0005	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.00011	0.000961	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000109	0.000958	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.000109	0.000955	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000108	0.000947	CbGpPWpGaD
Ciclesonide—Urticaria—Doxorubicin—lung cancer	0.000106	0.000479	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000106	0.000926	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000105	0.000918	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000104	0.000915	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000104	0.000915	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000103	0.000906	CbGpPWpGaD
Ciclesonide—Dizziness—Methotrexate—lung cancer	0.000102	0.00046	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000101	0.000885	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	9.92e-05	0.00087	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	9.91e-05	0.000869	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	9.89e-05	0.000867	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—KHSRP—lung cancer	9.88e-05	0.000866	CbGpPWpGaD
Ciclesonide—Rash—Methotrexate—lung cancer	9.69e-05	0.000439	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—lung cancer	9.68e-05	0.000439	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	9.68e-05	0.000849	CbGpPWpGaD
Ciclesonide—Headache—Methotrexate—lung cancer	9.63e-05	0.000436	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—GSTA4—lung cancer	9.58e-05	0.00084	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.55e-05	0.000838	CbGpPWpGaD
Ciclesonide—Asthenia—Doxorubicin—lung cancer	9.55e-05	0.000433	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	9.45e-05	0.000828	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTA2—lung cancer	9.33e-05	0.000819	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—lung cancer	9.15e-05	0.000803	CbGpPWpGaD
Ciclesonide—Nausea—Methotrexate—lung cancer	9.13e-05	0.000414	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—GSTA1—lung cancer	9.01e-05	0.00079	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.95e-05	0.000785	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2E1—lung cancer	8.88e-05	0.000778	CbGpPWpGaD
Ciclesonide—Dizziness—Doxorubicin—lung cancer	8.8e-05	0.000399	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	8.75e-05	0.000768	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF2B5—lung cancer	8.63e-05	0.000757	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	8.51e-05	0.000746	CbGpPWpGaD
Ciclesonide—Rash—Doxorubicin—lung cancer	8.39e-05	0.00038	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—lung cancer	8.38e-05	0.00038	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—lung cancer	8.38e-05	0.000735	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—UGT1A1—lung cancer	8.37e-05	0.000734	CbGpPWpGaD
Ciclesonide—Headache—Doxorubicin—lung cancer	8.34e-05	0.000378	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	8.3e-05	0.000728	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	8.26e-05	0.000724	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CDKN1A—lung cancer	8.19e-05	0.000718	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	8.06e-05	0.000707	CbGpPWpGaD
Ciclesonide—Nausea—Doxorubicin—lung cancer	7.91e-05	0.000358	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	7.86e-05	0.000689	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	7.86e-05	0.000689	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	7.85e-05	0.000688	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DICER1—lung cancer	7.81e-05	0.000685	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	7.52e-05	0.000659	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.39e-05	0.000648	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	7.38e-05	0.000647	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—lung cancer	7.32e-05	0.000642	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—lung cancer	7.31e-05	0.000641	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	7.3e-05	0.00064	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	7.22e-05	0.000633	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.22e-05	0.000633	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.12e-05	0.000624	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—lung cancer	6.9e-05	0.000605	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	6.88e-05	0.000603	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GCLC—lung cancer	6.83e-05	0.000598	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	6.83e-05	0.000598	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	6.81e-05	0.000597	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SKI—lung cancer	6.74e-05	0.000591	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	6.74e-05	0.000591	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—lung cancer	6.73e-05	0.00059	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	6.63e-05	0.000582	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	6.38e-05	0.000559	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A1—lung cancer	6.38e-05	0.000559	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	6.29e-05	0.000552	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.85e-05	0.000513	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.8e-05	0.000509	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.72e-05	0.000502	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AZIN2—lung cancer	5.61e-05	0.000492	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COL4A3BP—lung cancer	5.61e-05	0.000492	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RARB—lung cancer	5.41e-05	0.000475	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NPPA—lung cancer	5.27e-05	0.000462	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—lung cancer	5.11e-05	0.000448	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.79e-05	0.00042	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ATP5H—lung cancer	4.77e-05	0.000418	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—POMC—lung cancer	4.75e-05	0.000417	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.72e-05	0.000414	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPB1—lung cancer	4.54e-05	0.000398	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	4.41e-05	0.000387	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.4e-05	0.000386	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.34e-05	0.00038	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLBD1—lung cancer	4.25e-05	0.000373	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	4.18e-05	0.000366	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.17e-05	0.000366	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.11e-05	0.000361	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH3—lung cancer	4e-05	0.00035	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B10—lung cancer	3.89e-05	0.000341	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—JUNB—lung cancer	3.79e-05	0.000332	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AZIN2—lung cancer	3.67e-05	0.000322	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.67e-05	0.000322	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CKB—lung cancer	3.61e-05	0.000317	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM2—lung cancer	3.4e-05	0.000298	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CNDP2—lung cancer	3.4e-05	0.000298	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTMR3—lung cancer	3.31e-05	0.00029	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PGAM1—lung cancer	3.22e-05	0.000283	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ATP5H—lung cancer	3.12e-05	0.000273	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—POMC—lung cancer	3.11e-05	0.000273	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2A7—lung cancer	3.07e-05	0.00027	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SDC4—lung cancer	3.01e-05	0.000264	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLBD1—lung cancer	2.78e-05	0.000244	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ERCC2—lung cancer	2.75e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RRM1—lung cancer	2.74e-05	0.00024	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA3—lung cancer	2.74e-05	0.00024	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—B4GALT5—lung cancer	2.58e-05	0.000226	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B10—lung cancer	2.54e-05	0.000223	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA4—lung cancer	2.51e-05	0.00022	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—lung cancer	2.48e-05	0.000217	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA2—lung cancer	2.44e-05	0.000214	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CKB—lung cancer	2.36e-05	0.000207	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTA1—lung cancer	2.36e-05	0.000207	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCC3—lung cancer	2.33e-05	0.000204	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKR1C1—lung cancer	2.26e-05	0.000198	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM2—lung cancer	2.22e-05	0.000195	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CNDP2—lung cancer	2.22e-05	0.000195	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UGT1A1—lung cancer	2.19e-05	0.000192	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTMR3—lung cancer	2.16e-05	0.00019	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GNG11—lung cancer	2.11e-05	0.000185	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PGAM1—lung cancer	2.11e-05	0.000185	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CREBBP—lung cancer	2.01e-05	0.000176	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDOA—lung cancer	2.01e-05	0.000176	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2A7—lung cancer	2.01e-05	0.000176	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SDC4—lung cancer	1.97e-05	0.000172	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA3—lung cancer	1.95e-05	0.000171	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADCY1—lung cancer	1.9e-05	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG2—lung cancer	1.9e-05	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPGDS—lung cancer	1.86e-05	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO2—lung cancer	1.86e-05	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.85e-05	0.000162	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—lung cancer	1.81e-05	0.000158	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RRM1—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA3—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2A6—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCLC—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO1—lung cancer	1.69e-05	0.000148	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—B4GALT5—lung cancer	1.68e-05	0.000148	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA4—lung cancer	1.64e-05	0.000144	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA2—lung cancer	1.6e-05	0.00014	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTA1—lung cancer	1.54e-05	0.000135	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCC3—lung cancer	1.52e-05	0.000134	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2E1—lung cancer	1.52e-05	0.000133	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NQO1—lung cancer	1.5e-05	0.000132	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKR1C1—lung cancer	1.47e-05	0.000129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.43e-05	0.000126	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GNG11—lung cancer	1.38e-05	0.000121	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—STK11—lung cancer	1.35e-05	0.000119	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDOA—lung cancer	1.31e-05	0.000115	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA3—lung cancer	1.28e-05	0.000112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—lung cancer	1.25e-05	0.00011	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADCY1—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG2—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—lung cancer	1.23e-05	0.000108	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAT—lung cancer	1.22e-05	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPGDS—lung cancer	1.22e-05	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO2—lung cancer	1.22e-05	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.000106	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—lung cancer	1.19e-05	0.000105	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—lung cancer	1.19e-05	0.000104	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—lung cancer	1.18e-05	0.000104	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCLC—lung cancer	1.17e-05	0.000102	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.17e-05	0.000102	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—lung cancer	1.16e-05	0.000102	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—lung cancer	1.15e-05	0.000101	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO1—lung cancer	1.11e-05	9.7e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A1—lung cancer	1.09e-05	9.56e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ERCC2—lung cancer	1.08e-05	9.48e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2E1—lung cancer	9.92e-06	8.7e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NQO1—lung cancer	9.81e-06	8.6e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA1—lung cancer	9.36e-06	8.2e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—STK11—lung cancer	8.85e-06	7.76e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—lung cancer	8.54e-06	7.49e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—lung cancer	8.28e-06	7.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—lung cancer	8.18e-06	7.18e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—POMC—lung cancer	8.13e-06	7.13e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAT—lung cancer	7.96e-06	6.98e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CREBBP—lung cancer	7.92e-06	6.94e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—lung cancer	7.75e-06	6.79e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—lung cancer	7.61e-06	6.67e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—lung cancer	7.52e-06	6.6e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—lung cancer	7.51e-06	6.58e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—lung cancer	7.41e-06	6.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A1—lung cancer	7.13e-06	6.25e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ERCC2—lung cancer	7.07e-06	6.2e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—lung cancer	6.55e-06	5.74e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—lung cancer	6.49e-06	5.69e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA1—lung cancer	6.12e-06	5.36e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—lung cancer	5.66e-06	4.96e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—lung cancer	5.58e-06	4.9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—EP300—lung cancer	5.39e-06	4.73e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—POMC—lung cancer	5.32e-06	4.66e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CREBBP—lung cancer	5.18e-06	4.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—lung cancer	4.91e-06	4.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—lung cancer	4.85e-06	4.25e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—lung cancer	4.28e-06	3.75e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—lung cancer	4.24e-06	3.72e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—lung cancer	3.99e-06	3.5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—lung cancer	3.7e-06	3.24e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—EP300—lung cancer	3.53e-06	3.09e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—lung cancer	3.26e-06	2.86e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—lung cancer	2.61e-06	2.29e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—lung cancer	2.13e-06	1.87e-05	CbGpPWpGaD
